Stock Analiz

Aemetis, Inc. AMTX

Major Chemicals · data as of November 13, 2026

$1.20Market cap $88M
Open the interactive analysis →

Aemetis, Inc. (AMTX) is a industrial company listed in the US with a market value of about $88M. In the twelve months to September 30, 2026 it had revenue of $249M and net income of -$31M, a net margin of -12.5%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 4% a year, a 5-year average ROIC of -41%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 65% below the current price.

About Aemetis

Aemetis is listed in the US and classified in major chemicals. Revenue went from $208M in 2014 to $198M in 2025, a decline of about 0.5% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 73% over three years (dilution for shareholders).

Score: 0.8 / 5

Value0/5
Future growth2/5
Track record1/5
Financial health0/5
Shareholder returns1/5

Checks passed

  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • ROE above 15%
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.4
P/B—
EV/EBITDA19.0
PEG—
Dividend yield0.00%
FCF yield-41.7%
Shareholder yield0.0%
Intrinsic value vs. price−65%

Growth and quality

Revenue growth (1 yr)-26.2%
Revenue growth (5 yrs, per year)3.6%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-107.5%
ROIC (5-yr avg.)-40.6%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$249M$198M$268M$77M$28M$212M$166M$202M$172M$150M$143M
Net income-$31M-$77M-$88M-$46M-$108M-$47M-$37M-$39M-$36M-$32M-$16M
Free cash flow-$37M-$23M-$53M-$19M-$62M-$47M-$17M-$11M-$10M-$10M-$258000
EPS (diluted)$-0.52$-1.28$-1.91$-1.22$-3.12$-1.54$-1.74$-1.75$-0.00$-0.00$-0.00
Net margin-12.5%-39.0%-32.7%-60.1%-383.3%-22.2%-22.1%-19.5%-21.2%-21.2%-10.9%
ROIC—-38.7%-47.0%-37.0%-57.9%-22.2%-9.9%-12.3%-20.4%-16.1%-1.2%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Aemetis stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 65% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Aemetis pay a dividend?

Not currently.

Is Aemetis a good stock to buy?

We do not give buy or sell advice. Aemetis scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.